On the public citation graph

Parallel Trade Restraints in Pharmaceuticals and EU Competition Rules

https://doi.org/10.2139/ssrn.2334286
0 signed · 25 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1007/978-1-349-14129-6_23openalex-extracted
Intellectual Property and Competition Law
inferredcites →https://doi.org/10.1016/j.jhealeco.2004.03.005openalex-extracted
Parallel imports and the pricing of pharmaceutical products: evidence from the European Union
inferredcites →https://doi.org/10.1016/j.jinteco.2006.08.001openalex-extracted
Why parallel trade may raise producers' profits
inferredcites →https://doi.org/10.1016/s0167-6296(02)00035-8openalex-extracted
Should the US allow prescription drug reimports from Canada?
inferredcites →https://doi.org/10.1016/s0167-6296(02)00126-1openalex-extracted
The price of innovation: new estimates of drug development costs
inferredcites →https://doi.org/10.1016/s0172-2190(79)90045-0openalex-extracted
Commission of the European communities
inferredcites →https://doi.org/10.1073/pnas.93.9.3958openalex-extracted
Assignment of Rfp-Y to the chicken major histocompatibility complex/NOR microchromosome and evidence for high-frequency recombination associated with the nucleolar organizer region.
inferredcites →https://doi.org/10.1093/oso/9780190623784.001.0001openalex-extracted
Pharmaceutical Economics and Policy
inferredcites →https://doi.org/10.1093/oso/9780195300956.001.0001openalex-extracted
Pharmaceutical Economics And Policy
inferredcites →https://doi.org/10.1093/oso/9780199254286.001.0001openalex-extracted
Intellectual Property Rights, External Effects And Anti-Trust Law
inferredcites →https://doi.org/10.1177/009885880603200204openalex-extracted
How Parallel Trade Affects Drug Policies and Prices in Canada and the United States
inferredcites →https://doi.org/10.1287/mksc.19.3.279.11799openalex-extracted
Parallel Imports: Challenges from Unauthorized Distribution Channels
inferredcites →https://doi.org/10.2139/ssrn.1081332openalex-extracted
Competition, Patents and Innovation
inferredcites →https://doi.org/10.2139/ssrn.258289openalex-extracted
inferredcites →https://doi.org/10.2139/ssrn.582602openalex-extracted
Property, Intellectual Property, and Free Riding
inferredcites →https://doi.org/10.2139/ssrn.770228openalex-extracted
Why Parallel Trade May Raise Producers Profits
inferredcites →https://doi.org/10.2165/00019053-199813030-00004openalex-extracted
The Economics of Parallel Trade
inferredcites →https://doi.org/10.2165/00019053-200018060-00001openalex-extracted
The Single Market for Pharmaceuticals in the European Union in Light of European Court of Justice Rulings
inferredcites →https://doi.org/10.2307/1290378openalex-extracted
Limiting Patentees' Market Power without Reducing Innovation Incentives: The Perverse Benefits of Uncertainty and Non-Injunctive Remedies
inferredcites →https://doi.org/10.2307/840974openalex-extracted
Law and Competition in Twentieth Century Europe: Protecting Prometheus
inferredcites →https://doi.org/10.4324/9781315161921-9openalex-extracted
Competition as a Discovery Procedure
inferredcites →https://doi.org/10.4337/9781784713775openalex-extracted
Intellectual Property and Competition
inferredcites →https://doi.org/10.5040/9781472559838.ch-020openalex-extracted
Anticompetitive Abuses under Article 82 Involving Intellectual Property Rights
inferredcites →https://doi.org/10.6092/unibo/amsdottorato/3116openalex-extracted
Competition and Innovation in the EU Regulation of Pharmaceuticals: The Case of Parallel Trade
inferredcites →https://doi.org/10.7215/ip_ip_20080820openalex-extracted
Intellectual Property and Competition Law
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.